SurgWeek-2: Identifying the Global Burden of Post Operative Complications: an International Prospective Cohort Study Protocol
SurgWeek-2
1 other identifier
observational
100,000
0 countries
N/A
Brief Summary
This study aims to assess and improve the global outcomes following surgery. Every year approximately 313 million operations are performed, with 50 million people experiencing a complication and unfortunately 3.5 million people will die following these operations. This study will assess how outcomes vary following surgery throughout the world and explore system access, quality and efficiency. The secondary aims of this study are to (1) assess the use of antibiotics and the impact of resistant organisms globally, (2) assess who dies after an operation and whether there are factors that were identified that could have prevented the death, (3) assess the assess and outcomes to minimally invasive and robotic surgery, (4) assess the outcomes of the Bellwether procedures (laparotomy, caesarean delivery, open fracture management) as these are conditions used to assess the functioning of a health system. The study will take place for six week in May-June 2026 and will aim to collect data from 100,000 patients across 1000 hospitals in 100 countries to give a global perspective on the above outcome measures. The data will be analysed by hospital income group to understand how resources impact on outcomes. By combining global data on clinical outcomes with information on hospital resources, this study hopes to provide valuable insights into how to improve surgical care across diverse settings, making recommendations that lead to better access to safe, timely and affordable care for surgical problems worldwide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2026
CompletedFirst Posted
Study publicly available on registry
August 25, 2026
CompletedStudy Start
First participant enrolled
August 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
August 25, 2026
July 1, 2026
2 months
August 20, 2026
August 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global variation in post operative complications.
The primary aim of SurgWeek-2 is to assess the global burden and variation of postoperative complications. We will determine the frequency of postoperative complications across low-, middle- and high-income countries, further stratifying by age, sex, and surgical speciality.
30 days
Secondary Outcomes (5)
Global variation in postoperative infective complication and antimicrobial resistance rates.
30 days
Global variation in postoperative mortality rates and underlying reasons for postoperative mortality.
30 days
Global variation in access to and outcomes associated with minimally invasive and robotic surgery.
30 days
Global variation in the outcomes of the Bellwether procedures (laparotomy, caesarean delivery and open fracture management)
30 days
30-day Clavien-Dindo complication grade.
30 days
Study Arms (1)
Patients undergoing surgery
Patients undergoing surgery
Eligibility Criteria
All consecutive patients undergoing surgery
You may qualify if:
- All surgical specialties can participate including acute care surgery, breast surgery, cardiac surgery, colorectal surgery, general surgery, gynaecology, hepatobiliary surgery, neurosurgery, obstetrics, oesophagogastric surgery, ophthalmology, oral and maxillofacial surgery, orthopaedics, otolaryngology, paediatric surgery, plastic surgery, thoracic surgery, transplant surgery, trauma surgery, urology and vascular surgery.
- Patients undergoing both day case surgery and inpatient surgery should be included.
You may not qualify if:
- Patients who do not undergo an operation (e.g. planned operations that are cancelled).
- Patients undergoing angiography or minor procedures.
- Procedures performed outside of an operating theatre
- Individual participating centres can choose to include children only, adults only, or both children and adults. If including children or adults only, an age cut off should be selected that is appropriate to the local context.
- Each individual patient should only be included in the study once, based on the first operation they undergo within the data capture window. Therefore, patients who are re-operated within 30-days should only be entered once.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2026
First Posted
August 25, 2026
Study Start
August 31, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
August 25, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
SurgWeek-2 is collecting only routinely collected hospital data, seeking to measure current clinical practice.